Sex-specific trends in thyroid cancer incidence and histological patterns in Northern Tunisia: a population-based study with implications for cancer control and prevention
Open accessAbstract
Background: Thyroid cancer (TC) represents the most common endocrine malignancy worldwide, with incidence increasing rapidly across diverse geographic regions. However, population-based evidence from North Africa remains limited, and comprehensive longitudinal analyses examining sex-specific incidence patterns, histological subtypes, and trends in tumor extension are lacking in Tunisia. Aim: This study aimed to (i) quantify TC incidence trends by sex and age group, (ii) characterize histological subtype-specific temporal patterns and tumor extension at diagnosis in northern Tunisia between 2000 and 2018, and (iii) to address projections in incidence by sex until 2040. Methods: A retrospective, population-based registry study was conducted using data from the Northern Tunisia Cancer Registry (NTCR), covering 11 governorates with a population of 5,233,700 in 2018. All primary invasive TC cases diagnosed between 2000 and 2018 were included (n = 3639). Age-standardized incidence rates (ASIRs) were calculated using the WHO standard population. Temporal trends were assessed using Joinpoint regression to estimate average annual percentage change (AAPC) with 95% confidence intervals. Projections of TC incidence to 2040 were generated using Bayesian autoregressive age–period–cohort models. Results: TC incidence increased significantly between 2000 and 2018, with overall ASIR rising from 2.8 to 5.0 per 100,000 person-years (AAPC = 3.8%, p < 0.001). In males, ASIR increased from 0.9 to 2.4 (AAPC = 3.0%, p < 0.001), while in females it rose from 3.7 to 7.8 (AAPC = 4.3%, 95% CI: 3.0–5.7; p < 0.001). The increase was predominantly driven by papillary thyroid carcinoma (PTC) (AAPC = 6.4% in males; 5.8% in females; both p < 0.001), whereas follicular thyroid carcinoma (FTC) remained stable. Notably, the proportion of metastatic cases decreased significantly in females (AAPC = −7.2%, p = 0.033), and the proportion of regionally advanced disease decreased in males (AAPC = −5.0%, p = 0.034). Conclusions: This population-based study demonstrates a sustained rise in TC incidence in northern Tunisia, disproportionately affecting women and largely driven by papillary histology. The concurrent increase in TC incidence alongside a reduction in regional and metastatic extension at diagnosis occurred. These findings have important implications for cancer prevention and control, highlighting the need for risk-adapted screening strategies and rationalized diagnostic practices.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The thyroid cancer incidence data from Northern Tunisia, combined with regional epidemiological context, indicates the importance of validation in non-Western populations where cancer risk factor profiles and healthcare system characteristics may differ substantially from populations dominating existing XAI oncology research.
“The thyroid cancer incidence data from Northern Tunisia generated by the research team (Khiari et al., 2026), combined with the regional epidemiological context it provides, indicates the importance of validation in non-Western populations where cancer risk factor profiles and healthcare system characteristics may differ substantially from the populations that dominate existing XAI oncology”
From A generative AI multi-agent framework with integrated XAI governance for cancer diagnostics: from multi-omics interpretation to lifestyle risk stratification (2026) · cites this paper as Khiari et al., 2026
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024) · CA: a cancer journal for clinicians · doi:10.3322/caac.21834 · Cited by 27,064 · see citing works
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358 · see citing works
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535 · see citing works
Fellegi, I. P., & Sunter, A. B. (1969) · Journal of the American Statistical Association · doi:10.1080/01621459.1969.10501049 · Cited by 2,520 · see citing works
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604412 · Cited by 1,145 · see citing works
Pizzato, M., Li, M., Vignat, J., Laversanne, M., Singh, D., Vecchia, C. L., & Vaccarella, S. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00035-3 · Cited by 724 · see citing works
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
Miranda‐Filho, A., Lortet‐Tieulent, J., Bray, F., Cao, B., Franceschi, S., Vaccarella, S., & Maso, L. D. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00027-9 · Cited by 605 · see citing works
Global trends in thyroid cancer incidence and the impact of overdiagnosis
Li, M., Maso, L. D., & Vaccarella, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30115-7 · Cited by 436 · see citing works
Global Burden of Thyroid Cancer From 1990 to 2017
Deng, Y., Li, H., Wang, M., Li, N., Tian, T., Wu, Y., Xu, P., Yang, S., Zhai, Z., Zhou, L., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8759 · Cited by 355 · see citing works
Thyroid Cancer Incidence and Mortality Trends in the United States: 2000–2018
Megwalu, U. C., & Moon, P. K. (2022) · Thyroid · doi:10.1089/thy.2021.0662 · Cited by 311 · see citing works
Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact
Kim, H., Chen, H., Byrne, J., Wheeler, B., & Feuer, E. J. (2022) · Statistics in Medicine · doi:10.1002/sim.9407 · Cited by 283 · see citing works
Direct Standardization (Age-Adjusted Death Rates)
Curtin, L. R., & Klein, R. J. (1995) · PsycEXTRA Dataset · doi:10.1037/e584012012-001 · Cited by 252 · see citing works
Schouten, L. J., Jäger, J., & van den Brandt, P. A. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.464 · Cited by 122 · see citing works
Pereira, M. M., Williams, V. L., Johnson, J. E. H., & Valderrábano, P. (2020) · Thyroid · doi:10.1089/thy.2019.0415 · Cited by 116 · see citing works
Obesity and Thyroid Cancer Risk: An Update
Franchini, F., Palatucci, G., Colao, A., Ungaro, P., Macchia, P. E., & Nettore, I. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031116 · Cited by 108 · see citing works
Défossez, G., Uhry, Z., Delafosse, P., Dantony, E., d’Almeida, T. C., Plouvier, S., Bossard, N., Bouvier, A., Molinié, F., Woronoff, A., et al. (2021) · BMC Cancer · doi:10.1186/s12885-021-08261-1 · Cited by 85 · see citing works
Bao, W., Zi, H., Yuan, Q., Li, L., & Deng, T. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14099 · Cited by 73 · see citing works
Albarqouni, L., Arab‐Zozani, M., Abukmail, E., Greenwood, H., Pathirana, T., Clark, J. M., Kopitowski, K. S., Johansson, M., Born, K. B., Lang, E., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008696 · Cited by 61 · see citing works
Kwon, H., Han, K., & Park, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-38203-0 · Cited by 50 · see citing works
Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis
Panato, C., Vaccarella, S., Dal Maso, L., Basu, P., Franceschi, S., Serraino, D., Wang, K., Lei, F., Chen, Q., Huang, B., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa192 · Cited by 49 · see citing works
Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
Oh, C., Lim, J., Jung, Y., Kim, Y., Jung, K., Hong, S., & Won, Y. (2021) · Cancer Medicine · doi:10.1002/cam4.3926 · Cited by 46 · see citing works
Giusti, F., Martos, C., Carvalho, R., Eycken, L. J. V., Visser, O. J., & Bettio, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1219128 · Cited by 30 · see citing works
Incidence and mortality trends of thyroid cancer from 1980 to 2016
Wirth, S., Syleouni, M., Karavasiloglou, N., Rinaldi, S., Korol, D., Wanner, M., & Rohrmann, S. (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.w30029 · Cited by 24 · see citing works
Xu, L., Cao, Z. X., Weng, X., & Wang, C. F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1133098 · Cited by 22 · see citing works
Trends in thyroid cancer burden in Taiwan over two decades
Cheng, S. Y.-H., Hsu, Y., & Cheng, S. (2023) · Cancer Causes & Control · doi:10.1007/s10552-023-01694-y · Cited by 20 · see citing works
National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
Azangou‐Khyavy, M., Moghaddam, S. S., Rezaei, N., Esfahani, Z., Rezaei, N., Azadnajafabad, S., Rashidi, M., Mohammadi, E., Collaborators, G. 2. I. T. C., Azangou‐Khyavy, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17115-0 · Cited by 15 · see citing works
The growing global burden of thyroid cancer overdiagnosis
Kitahara, C. M. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00269-9 · Cited by 7 · see citing works
Completeness Evaluation of Adult-Population-Based Cancer Registries: A Systematic Review
Sousa, M. P., Monjardino, T., Santos, C., Lara, L., & Bento, M. J. (2025) · Cancers · doi:10.3390/cancers17071123 · Cited by 7 · see citing works
Thayer, M. B., Khanchel, F., Helal, I., Chiboub, D., Hedhli, R., Brahim, E. B., Jouini, R., & Chadli‐Debbiche, A. (2023) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.147 · Cited by 5 · see citing works
Profil épidémiologique des cancers différenciés de la thyroïde en Tunisie
Sellem, D. B., Zaabar, L., & Letaief, B. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.06.497 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- [16]Zoghlami N. Chihaoui N. Letaief A. Aounallah-Skhiri H. Ben Mansour N. Skhiri A. Ben Slama F. Hsairi M. Jing L. Health State of the Tunisian Population Evaluated by the Tunisian Health Examination Survey (THES-2016) DataSuds 2024 10.23708/PRDTYS · DOI
- [21]Boyle P. Parkin D. Cancer Registration: Principles and Methods; Statistical methods for registries IARC Scientific Publication No. 95 IARC Scientific Publication Lyon, France 1991 126 158 1894318
- [25]Riddle B.L. Eliassen M.S. Celaya M.O. Bancroft C. Johnson A. Oh J. Chawla C. Rees J.R. Identifying duplicate cancer cases across state boundaries: Pseudonymization as a method to encrypt identifiers J. Regist. Manag. 2023 49 88 91 PMC10198410 37260926
- [30]Yang Y. Land K.C. Age-Period-Cohort Analysis: New Models, Methods, and Empirical Applications Taylor & Francis Boca Raton, FL, USA 2013
- [38]Alshehri B. Descriptive epidemiological analysis of thyroid cancer in the Saudi population (2001-2013) Asian Pac. J. Cancer Prev. 2017 18 1445 1449 28612600 PMC5555560
Cited by
Sorted by citations
Barki, C., Chouchen, M., Sediri, A., Ceylan, H. İ., Rahmouni, H. B., Muntean, R. I., El-Seedi, H. R., Bragazzi, N. L., & Dergaa, I. (2026) · Frontiers in Systems Biology · doi:10.3389/fsysb.2026.1892418 · Cited by 1 · see citing works
“The thyroid cancer incidence data from Northern Tunisia generated by the research team (Khiari et al., 2026), combined with the regional epidemiological context it provides, indicates the importance of validation in non-Western populations where cancer risk factor profiles and healthcare system…”
Self-citation
- Authors
- Khiari, H., Henchiri, S., Dergaa, I., Ceylan, H. İ., Stefanica, V., Sakhri, S., Zarraa, S., Ben Mansour, H., Zenzri, Y., Dziri, H., Mansour, N. B., Mahjoub, N., Muntean, R. I., & Hsairi, M.
- Affiliations
- Department of Epidemiology, Salah Azaiez Institute of Cancer, Bab Saadoun, Tunis 1006, Tunisia
- Directorate of Basic Healthcare, Tunis 1002, Tunisia
- University of Jendouba (TN)
- Physical Education and Sports Teaching Department, Faculty of Sports Sciences, Atatürk University, Erzurum 25240, Türkiye
- Department of Physical Education and Sport, Faculty of Sciences, Physical Education and Informatics, Pitesti University Center, National University of Science and Technology Politehnica Bucharest, 060042 Pitesti, Romania
- Institut Salah-Azaïz (TN)
- Department of Radiotherapy, Salah Azaiez Institute of Cancer, Tunis 1007, Tunisia
- Department of Medical Oncology, Salah Azaiez Institute of Cancer, Tunis 1007, Tunisia
- Hôpital Charles-Nicolle (TN)
- 1 Decembrie 1918 University (RO)
- Corresponding author
- Muntean, Raul Ioan
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2026-05-03
- Volume
- 18
- Issue
- 9
- Pages
- 1472
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC13162613
- OpenAlex
- W7160056227
- Cited by
- 1
- References
- 28
- Citations by year
- 2026: 1
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- thyroid cancer, incidence trends, sex differences, papillary thyroid carcinoma, follicular thyroid carcinoma, histological subtypes, metastasis, metastatic disease, regional lymph node metastasis, age-standardized incidence rate, incidence projections, cancer control, Tunisia, North Africa, cancer registry data, age-period-cohort model, joinpoint regression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review